Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


21.05.2018

1 Am J Pathol
2 Am J Respir Crit Care Med
1 Ann Oncol
1 Ann Thorac Surg
1 Cancer Cell
1 Cancer Lett
1 Chest
4 Clin Lung Cancer
2 J Cancer Res Clin Oncol
2 J Clin Oncol
1 J Immunol
1 J Natl Cancer Inst
2 J Thorac Cardiovasc Surg
4 J Thorac Oncol
1 Oncogene
1 Oncol Rep


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Pathol

  1. YANAGITA K, Nagashio R, Jiang SX, Kuchitsu Y, et al
    Cytoskeleton-Associated Protein 4 Is a Novel Serodiagnostic Marker for Lung Cancer.
    Am J Pathol. 2018 May 2. pii: S0002-9440(17)30976.
    PubMed     Text format     Abstract available


    Am J Respir Crit Care Med

  2. FRIDLENDER ZG
    Myeloid Regulatory Cells - New and Exciting Players in the Immunology of Lung Cancer.
    Am J Respir Crit Care Med. 2018 May 14. doi: 10.1164/rccm.201804-0742.
    PubMed     Text format    

  3. BEATTIE J, Yarmus L, Wahidi M, Rivera MP, et al
    The Immune Landscape of Non-Small Cell Lung Cancer: Utility of Cytologic and Histologic Samples Obtained Through Minimally Invasive Pulmonary Procedures.
    Am J Respir Crit Care Med. 2018 May 14. doi: 10.1164/rccm.201712-2539.
    PubMed     Text format     Abstract available


    Ann Oncol

  4. GERBER DE, Horn L, Boyer M, Sanborn R, et al
    Randomized phase 3 study of docetaxel plus bavituximab in previously treated advanced non-squamous non-small-cell lung cancer.
    Ann Oncol. 2018 May 14. pii: 4996069. doi: 10.1093.
    PubMed     Text format     Abstract available


    Ann Thorac Surg

  5. WANG SC, Patel H, Scott WW
    Lung Cancer Invading a Coronary Graft: Role of Coronary Intervention and Robotic Surgery.
    Ann Thorac Surg. 2018 May 11. pii: S0003-4975(18)30654.
    PubMed     Text format     Abstract available


    Cancer Cell

  6. FRUH M, Peters S
    Genomic Features of Response to Combination Immunotherapy in Lung Cancer.
    Cancer Cell. 2018;33:791-793.
    PubMed     Text format     Abstract available


    Cancer Lett

  7. LU T, Li Z, Yang Y, Ji W, et al
    Corrigendum to "The Hippo/YAP1 pathway interacts with FGFR1 signaling to maintain stemness in lung cancer" [Canc. Lett. 423 (2018) 36-46].
    Cancer Lett. 2018 May 10. pii: S0304-3835(18)30275.
    PubMed     Text format    


    Chest

  8. ZHANG Y, Zheng D, Xie J, Li Y, et al
    Development and validation of web-based nomograms to precisely predict conditional risk of site-specific recurrence for patients with completely resected non-small cell lung cancer: a multi-institutional study.
    Chest. 2018 May 11. pii: S0012-3692(18)30731-1. doi: 10.1016/j.chest.2018.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  9. HIRSCH FR, Kerr KM, Bunn PA Jr, Kim ES, et al
    Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.
    Clin Lung Cancer. 2018 Mar 21. pii: S1525-7304(18)30056.
    PubMed     Text format     Abstract available

  10. GIULIANI M, Mathew AS, Bahig H, Bratman SV, et al
    SUNSET: Stereotactic Radiation for Ultracentral Non-Small-Cell Lung Cancer-A Safety and Efficacy Trial.
    Clin Lung Cancer. 2018 Apr 18. pii: S1525-7304(18)30073.
    PubMed     Text format     Abstract available

  11. CHIN AL, Kumar KA, Guo HH, Maxim PG, et al
    Prognostic Value of Pretreatment FDG-PET Parameters in High-dose Image-guided Radiotherapy for Oligometastatic Non-Small-cell Lung Cancer.
    Clin Lung Cancer. 2018 Apr 19. pii: S1525-7304(18)30085.
    PubMed     Text format     Abstract available

  12. DEEK MP, Kim S, Beck R, Yegya-Raman N, et al
    Variations in Initiation Dates of Chemotherapy and Radiation Therapy for Definitive Management of Inoperable Non-Small Cell Lung Cancer Are Associated With Decreases in Overall Survival.
    Clin Lung Cancer. 2018 Mar 17. pii: S1525-7304(18)30049.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  13. MEIER-SCHROERS M, Schild HH, Thomas D
    Response to "Commentary on: Lung cancer screening with MRI: results of the first screening round": Ngam Pei Ing et al.
    J Cancer Res Clin Oncol. 2018 May 14. pii: 10.1007/s00432-018-2660.
    PubMed     Text format    

  14. HANKE NT, Imler E, Marron MT, Seligmann BE, et al
    Characterization of carfilzomib-resistant non-small cell lung cancer cell lines.
    J Cancer Res Clin Oncol. 2018 May 15. pii: 10.1007/s00432-018-2662.
    PubMed     Text format     Abstract available


    J Clin Oncol

  15. COPUR MS, Crockett D, Gauchan D, Ramaekers R, et al
    Molecular Testing Guideline for the Selection of Patients With Lung Cancer for Targeted Therapy.
    J Clin Oncol. 2018 May 15:JCO2018788240. doi: 10.1200/JCO.2018.78.8240.
    PubMed     Text format    

  16. CAMIDGE DR, Kim DW, Tiseo M, Langer CJ, et al
    Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.
    J Clin Oncol. 2018 May 16:JCO2017775841. doi: 10.1200/JCO.2017.77.5841.
    PubMed     Text format     Abstract available


    J Immunol

  17. WANG Y, Schafer CC, Hough KP, Tousif S, et al
    Myeloid-Derived Suppressor Cells Impair B Cell Responses in Lung Cancer through IL-7 and STAT5.
    J Immunol. 2018 May 11. pii: jimmunol.1701069. doi: 10.4049/jimmunol.1701069.
    PubMed     Text format     Abstract available


    J Natl Cancer Inst

  18. RAFNAR T, Sigurjonsdottir GR, Stacey SN, Halldorsson G, et al
    Association of BRCA2 K3326* With Small Cell Lung Cancer and Squamous Cell Cancer of the Skin.
    J Natl Cancer Inst. 2018 May 14. pii: 4995938. doi: 10.1093.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  19. BRUNELLI A
    It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30962.
    PubMed     Text format    

  20. OKIROR L, Harling L, Toufektzian L, King J, et al
    Prognostic factors including lymphovascular invasion on survival for resected non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2018 Apr 12. pii: S0022-5223(18)30935.
    PubMed     Text format     Abstract available


    J Thorac Oncol

  21. GADGEEL SM, Pennell NA, Fidler MJ, Halmos B, et al
    Phase II study of maintenance pembrolizumab in patients with extensive-stage small cell lung cancer (SCLC).
    J Thorac Oncol. 2018 May 15. pii: S1556-0864(18)30600.
    PubMed     Text format     Abstract available

  22. KARANTH S, Rajan SS, Sharma G, Yamal JM, et al
    Racial-Ethnic Disparities in End-of-Life Care Quality among Lung Cancer Patients: A SEER-Medicare-Based Study.
    J Thorac Oncol. 2018 May 10. pii: S1556-0864(18)30540.
    PubMed     Text format     Abstract available

  23. WALTER JE, Heuvelmans MA, Yousaf-Khan U, Dorrius MD, et al
    New subsolid pulmonary nodules in lung cancer screening: a brief report of the NELSON trial.
    J Thorac Oncol. 2018 May 15. pii: S1556-0864(18)30605.
    PubMed     Text format     Abstract available

  24. SPIGEL DR, Chaft JE, Gettinger S, Chao BH, et al
    FIR: Efficacy, Safety, and Biomarker Analysis of a Phase II Open-Label Study of Atezolizumab in PD-L1-Selected Patients with Non-Small-Cell Lung Cancer.
    J Thorac Oncol. 2018 May 15. pii: S1556-0864(18)30603.
    PubMed     Text format     Abstract available


    Oncogene

  25. ZHAO C, Li Y, Qiu W, He F, et al
    C5a induces A549 cell proliferation of non-small cell lung cancer via GDF15 gene activation mediated by GCN5-dependent KLF5 acetylation.
    Oncogene. 2018 May 18. pii: 10.1038/s41388-018-0298.
    PubMed     Text format     Abstract available


    Oncol Rep

  26. WAN J, Ling X, Peng B, Ding G, et al
    miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.
    Oncol Rep. 2018 May 16. doi: 10.3892/or.2018.6439.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: